Human BioSciences, a leader in biotechnology and wound care solutions, is tackling one of our most pressing health challenges: diabetic wounds. With diabetes affecting over 500 million people ...
MediWound has commenced a pivotal, multicentre Phase III VALUE trial to assess its bioactive debridement therapy, EscharEx, ...